ANG Lifesciences India (BOM:540694) Inventories, Finished Goods: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540694 ANG Lifesciences India Ltd BOM:540694
63 GF Score
Price ₹26.95
GF Value ₹30.01
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is ANG Lifesciences India Inventories, Finished Goods?

ANG Lifesciences India BOM:540694 -4.97% 63 Inventories, Finished Goods is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:540694 with a GF Score™ of 63/100 and a GF Value™ of ₹30.01 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ANG Lifesciences India's annual finished goods increased from Mar. 2024 (₹151.4 Mil) to Mar. 2025 (₹176.7 Mil) but then declined from Mar. 2025 (₹176.7 Mil) to Mar. 2026 (₹0.0 Mil).

ANG Lifesciences India Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for ANG Lifesciences India's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ANG Lifesciences India Inventories, Finished Goods Chart

ANG Lifesciences India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 83.72 112.81 151.45 176.75 0.00

ANG Lifesciences India Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 176.75 0.00 0.00 0.00 0.00
BOM:540694
63GF Score
ANG Lifesciences India Ltd BOM:540694
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ANG Lifesciences India Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of ₹0.0 Mil mean?
ANG Lifesciences India (BOM:540694) has a Inventories, Finished Goods of ₹0.0 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on ANG Lifesciences India and its competitors.
Is ANG Lifesciences India's Inventories, Finished Goods too high?
ANG Lifesciences India's current Inventories, Finished Goods is ₹0.0 Mil. Overall, ANG Lifesciences India has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ANG Lifesciences India's Inventories, Finished Goods compare to ZTS?
ANG Lifesciences India's Inventories, Finished Goods of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on ANG Lifesciences India and its competitors. ANG Lifesciences India's current Inventories, Finished Goods is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ANG Lifesciences India stock overvalued right now?
Based on GuruFocus' analysis, ANG Lifesciences India (BOM:540694) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹30.01, compared to a current price of ₹26.95 — trading 10.2% below its estimated fair value. The current Inventories, Finished Goods is ₹0.0 Mil. ANG Lifesciences India's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For ANG Lifesciences India (BOM:540694), the current Inventories, Finished Goods is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ANG Lifesciences India (BOM:540694) Overvalued in 2026?

Based on GuruFocus' analysis, ANG Lifesciences India stock appears to be undervalued. The current stock price of ₹26.95 is trading 10.2% below its estimated GF Value™ of ₹30.01. GuruFocus considers ANG Lifesciences India to be Modestly Undervalued.

Key valuation signals for BOM:540694:

  • Inventories, Finished Goods: ₹0.0 Mil
  • GF Value™: ₹30.01 vs. price of ₹26.95 (10.2% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the BOM:540694 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ANG Lifesciences India Business Description

Address Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001
ANG Lifesciences India Ltd is engaged in the business of manufacturing and sales of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, lotions, etc. Its product portfolio comprises various therapeutic categories such as antibiotics, antivirals, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, beta-lactamase inhibitor, etc. Through its subsidiary, it is also involved in the business of printing and packing solutions. The group's reportable segments are Pharmaceuticals, which derive maximum revenue, and Packaging and printing. Geographically, it derives maximum revenue from India.
63GF Score

Get the complete analysis for BOM:540694

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹26.95
Price
₹30.01
GF Value